Gemcitabine Plus Paclitaxel in Treating Patients With Advanced Non-small Cell Lung Cancer or Other Solid Tumor

NCT00004159 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

54

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: gemcitabine hydrochloride
DRUG: paclitaxel

Sponsor

University of Alabama at Birmingham

Collaborators

[object Object]